CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | Hudson Paul Director | Grant or award | +6,139 | 6,139 | ||
| 2026-10-19 | Koppikar Utpal Director | Grant or award | +6,139 | 6,139 | ||
| 2026-09-09 | Brennan David R Director | Sale | −25,000 | $124.00 | $3.1M | 39,238 |
| 2026-08-17 | SHAROKY MELVIN MD Director | Sale | −5,000 | $127.53 | $638K | 0 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Option exercise | +82,280 | $13.67 | $1.1M | 181,024 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Option exercise | +76,600 | $17.16 | $1.3M | 257,624 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Option exercise | +80,970 | $30.46 | $2.5M | 338,594 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Sale | −239,850 | $133.27 | $32.0M | 98,744 |
| 2026-08-10 | Adsett Roger Chief Operating Officer | Option exercise · Stock Option (right to buy) | −82,280 | 0 | ||
| 2026-08-10 | Adsett Roger Chief Operating Officer | Option exercise · Stock Option (right to buy) | −76,600 | 0 | ||
| 2026-08-10 | Adsett Roger Chief Operating Officer | Option exercise · Stock Option (right to buy) | −80,970 | 0 | ||
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +18,278 | $18.95 | $346K | 78,764 |
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +8,895 | $25.83 | $230K | 87,659 |
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −8,895 | $127.00 | $1.1M | 78,764 |
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −18,278 | $129.40 | $2.4M | 60,486 |
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −18,278 | 36,555 | ||
| 2026-08-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,895 | 35,580 | ||
| 2026-07-23 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,260 | $30.46 | $191K | 265,318 |
| 2026-07-23 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 269,758 |
| 2026-07-23 | Lewis William Chair and CEO | Sale 10b5-1 | −4,828 | $105.62 | $510K | 264,930 |
Page 1 of 23 · 448 trades